Cathepsin G deficiency decreases complexity of atherosclerotic lesions in apolipoprotein E-deficient mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 305, Issue 8, 2013, Pages

  Rafatian, Naimeh ^a,b   Karunakaran, Denuja ^a   Rayner, Katey J ^a,b   Leenen, Frans H H ^a,b   Milne, Ross W ^a,b   Whitman, Stewart C ^a,b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Apo E; Atherosclerosis; Cathepsin G; Lesion progression

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; CATHEPSIN G; CHOLESTEROL; MESSENGER RNA; SERINE PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ARCH; AORTA INJURY; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; BONE MARROW; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENOTYPE; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

APO E; ATHEROSCLEROSIS; CATHEPSIN G; LESION PROGRESSION;

ANGIOTENSIN II; ANIMALS; AORTA; APOLIPOPROTEINS E; APOPTOSIS; ATHEROSCLEROSIS; CATHEPSIN G; DIET, HIGH-FAT; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; PHAGOCYTOSIS; PLAQUE, ATHEROSCLEROTIC;

EID: 84885580254     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00618.2012     Document Type: Article

References (32)

1. Abbott RE, Corral CJ, MacIvor DM, Lin X, Ley TJ, Mustoe TA. Augmented inflammatory responses and altered wound healing in cathepsin G-deficient mice. Arch Surg 133: 1002-1006, 1998.
2. Barnes MJ, Farndale RW. Collagens and atherosclerosis. Exp Gerontol 34: 513-525, 1999.
3. Barrett AJ. Cathepsin G. Methods Enzymol 80: 561-565, 1981.
4. Boehme MW, Galle P, Stremmel W. Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals. Immunology 107: 340-349, 2002.
5. Boisvert WA, Curtiss LK, Terkeltaub RA. Interleukin-8 and its receptor CXCR2 in atherosclerosis. Immunol Res 21: 129-137, 2000.
6. Bonnefoy A, Legrand C. Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase. Thromb Res 98: 323-332, 2000.
7. Boudier C, Holle C, Bieth JG. Stimulation of the elastolytic activity of leukocyte elastase by leukocyte cathepsin G. J Biol Chem 256: 10256-10258, 1981.
8. Capodici C, Berg RA. Cathepsin G degrades denatured collagen. Inflammation 13: 137-145, 1989.
9. Clarke MC, Figg N, Maguire JJ, Davenport AP, Goddard M, Littlewood TD, Bennett MR. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nature Med 12: 1075-1080, 2006.
10. Daugherty A, Whitman SC. Quantification of atherosclerosis in mice. Methods Mol Biol 209: 293-309, 2003.
11. de Nooijer R, Bot I, von der Thusen JH, Leeuwenburgh MA, Overkleeft HS, Kraaijeveld AO, Dorland R, van Santbrink PJ, van Heiningen SH, Westra MM, Kovanen PT, Jukema JW, van der Wall EE, van Berkel TJ, Shi GP, Biessen EA. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis. Arterioscler Thromb Vasc Biol 29: 188-194, 2009.
12. Dzau VJ, Gonzalez D, Kaempfer C, Dubin D, Wintroub BU. Human neutrophils release serine proteases capable of activating prorenin. Circ Res 60: 595-601, 1987.
13. Grisolano JL, Sclar GM, Ley TJ. Early myeloid cell-specific expression of the human cathepsin G gene in transgenic mice. Proc Natl Acad Sci USA 91: 8989-8993, 1994.
14. Guo J, Bot I, de Nooijer R, Hoffman SJ, Stroup GB, Biessen EA, Benson GM, Groot PH, Van Eck M, Van Berkel TJ. Leucocyte cathepsin K affects atherosclerotic lesion composition and bone mineral density in low-density lipoprotein receptor deficient mice. Cardiovasc Res 81: 278-285, 2009.
15. Guzik K, Bzowska M, Smagur J, Krupa O, Sieprawska M, Travis J, Potempa J. A new insight into phagocytosis of apoptotic cells: proteolytic enzymes divert the recognition and clearance of polymorphonuclear leukocytes by macrophages. Cell Death Differ 14: 171-182, 2007.
16. Hanson RD, Connolly NL, Burnett D, Campbell EJ, Senior RM, Ley TJ. Developmental regulation of the human cathepsin G gene in myelomonocytic cells. J Biol Chem 265: 1524-1530, 1990.
17. Kaschina E, Scholz H, Steckelings UM, Sommerfeld M, Kemnitz UR, Artuc M, Schmidt S, Unger T. Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components. Atherosclerosis 205: 396-403, 2009.
18. Leenen FH, White R, Yuan B. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system. Am J Physiol Heart Circ Physiol 281: H2410-H2416, 2001.
19. Legedz L, Randon J, Sessa C, Baguet JP, Feugier P, Cerutti C, McGregor J, Bricca G. Cathepsin G is associated with atheroma formation in human carotid artery. J Hypertens 22: 157-166, 2004.
20. Mazzolai L, Hayoz D. The renin-angiotensin system and atherosclerosis. Curr Hypertens Rep 8: 47-53, 2006.
21. McKellar GE, McCarey DW, Sattar N, McInnes IB. Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol 6: 410-417, 2009.
22. Ouimet M, Wang MD, Cadotte N, Ho K, Marcel YL. Epoxycholesterol impairs cholesteryl ester hydrolysis in macrophage foam cells, resulting in decreased cholesterol efflux. Arterioscler Thromb Vasc Biol 28: 1144-1150, 2008.
23. Owen CA, Campbell EJ. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition. J Immunol 160: 1436-1443, 1998.
24. Rafiq K, Hanscom M, Valerie K, Steinberg SF, Sabri A. Novel mode for neutrophil protease cathepsin G-mediated signaling: membrane shedding of epidermal growth factor is required for cardiomyocyte anoikis. Circ Res 102: 32-41, 2008.
25. Richter R, Bistrian R, Escher S, Forssmann WG, Vakili J, Henschler R, Spodsberg N, Frimpong-Boateng A, Forssmann U. Quantum proteolytic activation of chemokine CCL15 by neutrophil granulocytes modulates mononuclear cell adhesiveness. J Immunol 175: 1599-1608, 2005.
26. Saunders WB, Bayless KJ, Davis GE. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci 118: 2325-2340, 2005.
27. Tabas I. Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress. Antioxid Redox Signal 11: 2333-2339, 2009.
28. Thorp E, Tabas I. Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J Leukoc Biol 86: 1089-1095, 2009.
29. Vandivier RW, Fadok VA, Ogden CA, Hoffmann PR, Brain JD, Accurso FJ, Fisher JH, Greene KE, Henson PM. Impaired clearance of apoptotic cells from cystic fibrosis airways. Chest 121: 89, 2002.
30. Whitman SC. All of the components required for angiotensin II formation are expressed locally in human atherosclerotic lesions, including a long suspected player cathepsin G. J Hypertens 22: 39-42, 2004.
31. Whitman SC, Daugherty A, Post SR. Macrophage colony-stimulating factor rapidly enhances beta-migrating very low density lipoprotein metabolism in macrophages through activation of a Gi/o protein signaling pathway. J Biol Chem 275: 35807-35813, 2000.
32. Yancey PG, Blakemore J, Ding L, Fan D, Overton CD, Zhang Y, Linton MF, Fazio S. Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation. Arterioscler Thromb Vasc Bio 30: 787-795, 2010.